Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

JENBURKT PHARMACEUTICALS LTD.

NSE : NABSE : 524731ISIN CODE : INE354A01013Industry : Pharmaceuticals & DrugsHouse : Private

BSE1178.2015 (+1.29 %)

PREV CLOSE ( ) 1163.20

OPEN PRICE ( ) 1165.05

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 1841

TODAY'S LOW / HIGH ( )1165.00 1181.00

52 WK LOW / HIGH ( ) 9441410

NSE

This Company is not listed in NSE

Quarters

Select year

( in Million)

Particulars

Mar 2026

Dec 2025

Sep 2025

Jun 2025

Audited / UnAudited

UnAudited

Net Sales

446.32

430.24

455.58

355.27

Total Expenditure

303.83

355.94

324.54

265.69

PBIDT (Excl OI)

142.49

74.3

131.04

89.58

Other Income

43.48

18.15

20.79

20.57

Operating Profit

185.98

92.45

151.83

110.15

Interest

1.29

1.16

1.07

1.1

Exceptional Items

-39.51

PBDT

145.18

91.29

150.76

109.05

Depreciation

8.09

8.33

7.44

7.22

Profit Before Tax

137.09

82.96

143.32

101.83

Tax

28.59

23.65

41.69

23.9

Provisions and contingencies

Profit After Tax

108.5

59.31

101.63

77.93

Extraordinary Items

Prior Period Expenses

Other Adjustments

0.00

Net Profit

108.5

59.31

101.63

77.93

Equity Capital

44.13

Face Value (IN RS)

Reserves

Calculated EPS

24.58

13.43

23.02

17.65

Calculated EPS (Annualised)

98.34

53.75

92.11

70.63

No of Public Share Holdings

2355063

2354650

2354151

2353750

% of Public Share Holdings

53.36

53.35

53.34

53.33

PBIDTM% (Excl OI)

31.92

17.26

28.76

25.21

PBIDTM%

41.66

21.48

33.32

31.00

PBDTM%

32.52

21.21

33.09

30.69

PBTM%

30.71

19.28

31.45

28.66

PATM%

24.30

13.78

22.30

21.93

Notes

Risk Disclosures on Derivatives

Quarterly Results

JENBURKT PHARMACEUTICALS LTD.